Volume 2, Issue 3 (10-2022)                   Zoonosis 2022, 2(3): 40-48 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

akbari Z, babaei M. West Nile virus disease shared between humans and animals. Zoonosis 2022; 2 (3) :40-48
URL: http://zoonosis.ir/article-1-54-en.html
Student of Veterinary Medicine, Babol Islamic azad university, Mazandaran, Iran. , zahra.akbari3616@gmail.com
Abstract:   (422 Views)
     West Nile virus (WNV) is a microorganism that causes the spread of deadly diseases and is a common disease between animals and humans. West Nile virus is a member of the Flavivirus family, commonly found in Africa, Europe, the Middle East, North America, and West Asia. This virus infects birds, humans, horses, dogs, cats, bats, ferrets, and domestic rabbits. Our goal in this article is to further investigate this disease in terms of epidemiology, etiology, symptoms, methods of diagnosis, and treatment and to provide ways to prevent this common zoonotic disease. The primary way of infection in humans is through the bites of infected mosquitoes, but there are no reports of direct transmission of the disease from pets to humans. So far, the vaccine for this disease has been produced only for horses, and there is no human vaccine yet. The virus that causes this disease causes two forms of the disease in humans: 1- Mild form: without symptoms or with minor symptoms with an incubation period of 3-8 days, after which fever, headache, cold, weakness, swollen lymph nodes, Fatigue and bruises, skin rashes, vomiting, nausea, and diarrhea are observed. 2- Acute form: In this form, the nervous system is attacked, and the symptoms of encephalitis or meningitis are observed in patients. Due to the lack of a specific and effective medicine against the West Nile virus until today, disease prevention by informing doctors and public health officials for timely diagnosis and control of the virus and monitoring mosquitoes will be effective in reducing this disease. We have reviewed several articles about the West Nile virus through Google Scholar, Scopus, etc
Full-Text [PDF 524 kb]   (311 Downloads)    
Book Review: Review Article | Subject: Veterinary Virology
Received: 2022/11/30 | Accepted: 2022/12/18 | Published: 2022/12/21

References
1. Petersen, L.R.; Roehrig, J.T. West Nile virus: A reemerging global pathogen. Emerging Infectious Diseases. 2001, 7, 611-614. [DOI:10.3201/eid0704.017401] [PMID] [PMCID]
2. Hamman, M.H.; Delphine, H.C.; Winston, H.P. Antigenic variation of West Nile virus in relation to geography. American Journal of Epidemiology ,1965, 82, 40-55. [DOI:10.1093/oxfordjournals.aje.a120531]
3. Anderson, J.F.; Vossbrinck, C.R.; Andreadis, T.G.; Iton, A.; Beckwith, W.H., 3rd; Mayo, D.R. A phylogenetic approach to following West Nile virus in Connecticut. Proceedings of the National Academy of Sciences of the United States of America. 2001, 98, 12885-12889. [DOI:10.1073/pnas.241472398] [PMID] [PMCID]
4. Komar N, Clark G (2006) West Nile virus activity in Latin America and the Caribbean. Revista Panamericana de Salud Pública 19:112-117 [DOI:10.1590/S1020-49892006000200006] [PMID]
5. European Centre for Disease Prevention and Control. Epidemiological Update: West Nile Virus Transmission Season in Europe. Available online: https://www.ecdc.europa.eu/en/news-events/epidemiological-update-west-nile-virus-transmission-season- europe-2019
6. Mackenzie, J.S.; Gubler, D.J.; Petersen, L.R. Emerging flaviviruses: The spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nature Medicine. 2004, 10, S98-S109. [CrossRef] [PubMed] [DOI:10.1038/nm1144] [PMID]
7. Hubalek, Z.; Halouzka, J. West Nile fever-A reemerging mosquito-borne viral disease in Europe. Emerging Infectious Diseases. 1999, 5, 643-650. [CrossRef] 2. Hubalek, Z.; Rudolf, I.; Nowotny, N. Arboviruses pathogenic for domestic and wild animals. Advances in Virus Research. 2014, 89, 201-275. [CrossRef] [PubMed] [DOI:10.3201/eid0505.990505] [PMID] [PMCID]
8. Intrauterine West Nile virus infection-New York, 2002. Morbidity and Mortality Weekly Report. 2002;51 (50):1135-6. [PubMed: 12537289]
9. Alpert SG, Fergerson J, Noel LP. Intrauterine West Nile virus: ocular and systemic findingsAmerican Journal of Ophthalmology. 2003;136(4):733-5. [PubMed: 14516816] [DOI:10.1016/S0002-9394(03)00452-5] [PMID]
10. Hinckley AF, O'Leary DR, Hayes EB. Transmission of West Nile virus through human breast milk seems to be rare. Pediatrics 2007;119(3):e666-71. [PubMed: 17332186] [DOI:10.1542/peds.2006-2107] [PMID]
11. Hernandez-Triana, L.M.; Jeffries, C.L.; Mansfield, K.L.; Carnell, G.; Fooks, A.R.; Johnson, N. Emergence of West Nile virus lineage 2 in europe: A review on the introduction and spread of a mosquito-borne disease. Front. Public Health 2014, 2, 271. [CrossRef] [PubMed] [DOI:10.3389/fpubh.2014.00271] [PMID] [PMCID]
12. Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Annals of Internal Medicine. 2002;137(3): 173-9. [PubMed: 12160365] [DOI:10.7326/0003-4819-137-3-200208060-00009] [PMID]
13. Brilla R, et al. Clinical and neuroradiologic features of 39 consecutive cases of West Nile Virus meningoencephalitis .Journal of the Neurological Sciences 2004;220(1-2):37-40. [PubMed: 15140603] [DOI:10.1016/j.jns.2004.01.013] [PMID]
14. Tyler KL. West Nile virus infection in the United States. Archives of neurology. 2004;61(8):1190-5. [PubMed: 15313835] [DOI:10.1001/archneur.61.8.1190]
15. Van den Hurk AF, Hall-Mendelin S, Webb CE, Tan CS, Frentiu FD, Prow NA, Hall RA (2014) Role of enhanced vector transmission of a new West Nile virus strain in an outbreak of equine disease in Australia in 2011. Parasit Vectors 7:586 [DOI:10.1186/s13071-014-0586-3] [PMID] [PMCID]
16. Martina BE, Koraka P, Osterhaus AD (2010) West Nile virus: is a vaccine needed. Current Opinion in Investigational Drugs. 2011:139-146
17. Marasco WA, Sui J (2007) The growth and potential of human antiviral monoclonal antibody therapeutics. Nature Biotechnology. 25:1421-1434 [DOI:10.1038/nbt1363] [PMID] [PMCID]
18. Diamond MS, Sitati EM, Friend LD, Higgs S, Shrestha B, Engle M (2003) A critical role for induced IgM in the protection against West Nile virus infection .Journal of Experimental Medicine 198:1853-1862 [DOI:10.1084/jem.20031223] [PMID] [PMCID]
19. Lim SP, Shi PY (2013) West Nile virus drug discovery. Viruses 5:2977-3006 [DOI:10.3390/v5122977] [PMID] [PMCID]
20. Smithburn KC, Hughes TP, Burke AW, Paul JH. A neurotropic virus isolated from the blood of a native of Uganda The American Journal of Tropical Medicine 1940;20:471-492. [DOI:10.4269/ajtmh.1940.s1-20.471]
21. Mostashari F, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001;358(9278):261-4. [PubMed: 11498211] [DOI:10.1016/S0140-6736(01)05480-0] [PMID]
22. MacLachlan NJ, Dubovi EJ (2017) Fenner's veterinary virology, 5ed edn. Elsevier, London, p 581
23. Lindenbach, BD.; Rice, CM. Flaviviridae: the viruses and their replication. In: Knipe, HP., editor. Fields Virology. Lippincott, Williams, & Wilkins; Philadelphia: 2001. P. 991-1041.DM
24. Westaway EG, Ng ML. Replication of flaviviruses: separation of membrane translation sites of Kunjin
25. Miyanari Y, et al. The lipid droplet is an important organelle for hepatitis C virus productionNature Cell Biology. 2007;9(9):1089-97. [PubMed: 17721513] [DOI:10.1038/ncb1631] [PMID]
26. Miyanari Y, et al. Hepatitis C virus non-structural proteins in the probable membranous compartment function in viral genome replication. Journal of Biological Chemistry,2003;278(50):50301-8. [PubMed: 12963739] [DOI:10.1074/jbc.M305684200] [PMID]
27. Seligman, S.J.; Bucher, D.J. The importance of being outer: Consequences of the distinction between the outer and inner surfaces of flavivirus glycoprotein E. Trends in Microbiology. 2003, 11, 108-110. [DOI:10.1016/S0966-842X(03)00005-2] [PMID]
28. Tisiodras S, Kelesidis T, Kelesidis I, Bauchinger U, Falagas ME (2008) Human infections associated with wild birdsThe International Journal of Information Security. 56: 83-98 [DOI:10.1016/j.jinf.2007.11.001] [PMID] [PMCID]
29. Gubler DJ. Human Arbovirus Infections Worldwide. Annals of the New York Academy of Sciences. 2001; 951: 13-24. [DOI:10.1111/j.1749-6632.2001.tb02681.x] [PMID]
30. Hayes CG. West Nile Virus: Uganda, 1937, to New York City, 1999.Annals of the New York Academy of Sciences. 2001; 951: 25-37. [DOI:10.1111/j.1749-6632.2001.tb02682.x] [PMID]
31. Soliman A, Mohareb E, Salman D, Saad M, Salama S,Fayez C, et al. Studies on West Nile virus infection in Egypt. Journal of Infection and Public Health. 2010; 3: 54-59. [DOI:10.1016/j.jiph.2009.11.002] [PMID]
32. Roehr B. (2012). Texas records worst outbreak of West Nile virus on record.British Medical Journal (Clinical research ed.), 345, 6019. [DOI:10.1136/bmj.e6019] [PMID]
33. Epstein PR, Defilippo C. West Nile virus and drought. Global Change and Human Health. 2001; 2(2): 2-4. [DOI:10.1023/A:1015089901425]
34. Davis CT, Ebel GD, Lanciotti RS, Brault AC, Guzman H, Siirin M, Lambert A, Parsons RE, Beasley DW, Novak RJ, Elizondo- Quiroga D, Green EN, Young DS, Stark LM, Drebot MA, Artsob H, Tesh RB, Kramer LD, Barrett AD (2005) Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype. Virology 342:252-265 [DOI:10.1016/j.virol.2005.07.022] [PMID]
35. Delang, L.; Vliegen, I.; Froeyen, M.; Neyts, J. Comparative study of the genetic barriers and pathways towards resistance of selective inhibitors of hepatitis C virus replication. Antimicrob. Agents Chemother. 2011, 55, 4103-4113. [DOI:10.1128/AAC.00294-11] [PMID] [PMCID]
36. Beasley, D.W. Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus. Immunotherapy 2011, 3, 269-285. [DOI:10.2217/imt.10.93] [PMID]
37. Ng, T.; Hathaway, D.; Jennings, N.; Champ, D.; Chiang, Y.W.; Chu, H.J. Equine vaccine for West Nile virus. Developmental Biology (Basel) 2003, 114, 221-227
38. Wolf, R.F.; Papin, J.F.; Hines-Boykin, R.; Chavez-Suarez, M.; White, G.L.; Sakalian, M.; Dittmer, D.P. Baboon model for West Nile virus infection and vaccine evaluation. Virology 2006, 355, 44-51. [DOI:10.1016/j.virol.2006.06.033] [PMID]
39. Gao, M.; Nettles, R.E.; Belema, M.; Snyder, L.B.; Nguyen, V.N.; Fridell, R.A.; Serrano-Wu, M.H.; Langley, D.R.; Sun, J.H.; O'Boyle, D.R., II; et al. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 2010, 465, 96-100. [DOI:10.1038/nature08960] [PMID] [PMCID]
40. Bondre, V.P., Jadi, R.S., Mishra, A.C., Yergolkar, P.N., Arankalle, V.A., 2007. West Nile virus isolates from India: evidence for a distinct genetic lineage. Journal of General Virology 88 (Pt. 3), 875-884. [DOI:10.1099/vir.0.82403-0] [PMID]
41. Monaco F., Savini G., Calistri P., Polci A., Pinoni C., Bruno R., Lelli 286 R.,2011. 2009 West Nile disease epidemic in Italy: First evidence of overwintering in Western Europe Research in Veterinary Science 91,321 - 326. [DOI:10.1016/j.rvsc.2011.01.008] [PMID]
42. Castillo-Olivares J., Wood J., 2004. West Nile virus infection of horses. Veterinary Research. 35, 467-483. [DOI:10.1051/vetres:2004022] [PMID]
43. Burt F.J., Grobbelaar A.A., Leman P.A., Anthony F.S., Gibson G.V., Swanepoel R.,2002. Phylogenetic relationships of southern African West Nile virus isolates. Emerging Infectious Diseases. 8,820-826. [DOI:10.3201/eid0808.020027] [PMID] [PMCID]
44. Kondro W., 2006.West Nile virus still a threat. Can. The American Medical Association Journal. 175, 570 [DOI:10.1503/cmaj.061045] [PMID] [PMCID]
45. Saidi S., Tesh R., Javadian E., Nadim A.,1976. The prevalence of human infection with West Nile virus in Iran. Iranian Journal of Public Health. 5, 8-13.
46. Burgu I., Akça Y., Toker A., Alkan F.,1989. Atlarda enfeksiyöz anemi'nin serolojik olarak ara_tırılması. A Ü Vet Fak Derg 36(1),123-8.
47. Turan N, Yılmaz H, Uysal A, Arslan M.,2002. Seronegative findings on the investigations of equine infectious anemia in the Marmara region of Turkey. turkish journal veterinary and animal science. 26,299-302.
48. Ataseven V.S., Arslan H.H., 2005. Equine Infectious Anemia in Mules, Donkeys, and Horses: 190 Epidemiologic Studies in the Different Geographic Regions of Turkey. Journal of Equine Veterinary Science 25(10), 439-441. [DOI:10.1016/j.jevs.2005.09.007]
49. Bulut O., Yavru S., Yapici O., Kale M., Avci O., 2012. The Serological investigation of Equine Viral Arteritis Infection In Central Anatolia of Turkey. Journal of Animal & Veterinary Advances 11(7),924-926. [DOI:10.3923/javaa.2012.924.926]
50. Yamanaka, T., Niwa, H., Tsujimura, K., Kondo, T., Matsumura, T., 2008. Epidemic of equine influenza among vaccinated racehorses in Japan in 2007. Journal of Veterinary Science. 70, 623-625. [DOI:10.1292/jvms.70.623] [PMID]
51. Radostits, O. M. , C Gay, C. , Hinchcliff , K.W.,Constable , P.D. (2007). Veterinary Medicine, 10th ed. SAUNDERS ELSEVIER, 1173,1319,1322,.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Journal of Zoonosis

Designed & Developed by : Yektaweb